Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor. (2022)
Attributed to:
Defining the role of ERK5 kinase and ERK5 transcriptional activities in cell migration and EMT using novel ERK5 inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.1c01756
PubMed Identifier: 35468293
Publication URI: http://europepmc.org/abstract/MED/35468293
Type: Journal Article/Review
Volume: 65
Parent Publication: Journal of medicinal chemistry
Issue: 9
ISSN: 0022-2623